1. The Clinical Enigma of Cardiogenic Shock

3. Program Goals

4. Prevalence of Cardiogenic Shock

5. Clinical Scenario

6. Prompt Revascularization and Hemodynamic Support

7. Diagnosis and Classification

8. Signs and Symptoms of CS

9. CS Frequency, Trends, and Risk

10. Vasopressors vs Inotropes for Improvement in Organ Perfusion

11. SOAP II Trial – Norepinephrine vs Dopamine

12. Treatment Algorithm for Cardiogenic Shock

13. Potential CS Care Pathway

14. Device Selection

15. Types of pMCS Devices

16. Temporary pMCS vs Durable MCS

17. CS Center Characteristics

18. Reperfusion Strategy Selection

19. Delayed Implementation of Effective Therapies for Shock

20. The Role of Early RHC in CS Patients

21. Guideline Recommendations for Circulatory Support in Cardiogenic Shock

22. Prioritizing Lesion Revascularization

23. The Shock Team

24. Take Home Points

25. Conclusion

26. Abbreviations

27. Abbreviations (cont)

28. Abbreviations (cont)

29. Abbreviations (cont)